Tyrosine Protein Kinase SYK Market
Tyrosine Protein Kinase SYK Market Size, Share & Trends Analysis Report By Type (HMPL-523, C-13, CVXL-0074, ASN-002, FF-10102, and Others), By Application (Anaphylactic Shock, Arthritis, Fallopian Tube Cancer, Lupus Nephritis, and Others) Forecast Period, (2026-2035)
Industry Overview
Tyrosine protein kinase SYK market valued at $355.2 million in 2025 and is projected to reach $820.2 million by 2035, growing at a CAGR of 8.8% during the forecast period (2026-2035). The global tyrosine protein kinase SYK market is advancing steadily as pharmaceutical companies intensify efforts to develop targeted therapies for autoimmune disorders, hematologic malignancies, and inflammatory diseases. Spleen tyrosine kinase (SYK) plays a central role in B-cell receptor signaling and immune-cell activation, making it a critical therapeutic target across multiple immune-mediated conditions. Growing emphasis on precision-targeted kinase inhibition and oral small-molecule therapies is reinforcing investment in SYK-focused drug development. As clinical pipelines expand and strategic licensing agreements accelerate innovation, SYK inhibitors are emerging as an important segment within the broader kinase inhibitor market.
Market Dynamics
Expanding Clinical Applications in Autoimmune and Hematologic Disorders
SYK inhibition is increasingly being explored for diseases driven by aberrant immune signaling, including sickle cell disease and inflammatory conditions. In January 2025, Rigel Pharmaceuticals enrolled the first subject in a Phase I trial evaluating its oral SYK inhibitor fostamatinib for sickle cell disease, highlighting continued clinical interest in expanding SYK-targeted indications. Additionally, dual JAK/SYK inhibitors are advancing in late-stage development, reflecting growing confidence in SYK pathway modulation for immune-mediated diseases. In June 2025, Sanofi licensed gusacitinib, a dual JAK/SYK inhibitor, in a deal valued at up to €545 million, underscoring strategic investment in SYK-based therapeutics. These developments illustrate how broader immune-disease applications are strengthening the commercial outlook for SYK-targeted drugs.
Rising Strategic Partnerships and Licensing Activity
The competitive landscape is being shaped by collaborations aimed at accelerating development and commercialization. Large pharmaceutical companies are increasingly partnering with biotech innovators to secure access to differentiated kinase inhibitors. The Sanofi–Formation Bio agreement for gusacitinib reflects sustained industry interest in kinase platforms that combine SYK inhibition with complementary pathways. Such licensing models reduce development risk while expanding therapeutic reach, reinforcing long-term growth prospects for the SYK market.
Market Segmentation
- Based on the Type, the market is segmented into HMPL-523, C-13, CVXL-0074, ASN-002, FF-10102, and others.
- Based on the application, the market is segmented into anaphylactic shock, arthritis, fallopian tube cancer, lupus nephritis, and others.
HMPL-523 Segment to Lead the Market with the Largest Share
HMPL-523 is anticipated to hold a prominent share in the global Tyrosine Protein Kinase SYK market, driven by its advanced stage of clinical development and strong therapeutic potential in autoimmune and hematological disorders. As a selective SYK inhibitor, HMPL-523 has demonstrated encouraging efficacy and safety profiles in ongoing clinical studies, strengthening confidence among researchers and investors. The growing focus on targeted therapies that modulate immune signaling pathways further supports demand for SYK inhibitors such as HMPL-523. Additionally, strategic collaborations, licensing agreements, and expanding clinical pipelines are expected to reinforce the segment’s leadership position over the forecast period.
Arthritis Segment to Emerge as a Key Application Area
Based on application, arthritis represents a significant growth segment within the SYK inhibitor market, owing to the critical role of SYK signaling in inflammatory and autoimmune pathways associated with rheumatoid arthritis and related conditions. Increasing prevalence of autoimmune diseases worldwide, coupled with unmet clinical needs for patients unresponsive to conventional therapies, is accelerating research into novel SYK-targeted treatments. Targeted inhibition offers the potential for improved disease control with reduced systemic side effects compared to traditional immunosuppressive agents. As pharmaceutical companies continue to advance clinical programs for inflammatory indications, the arthritis segment is expected to contribute substantially to overall market expansion.
Regional Outlook
The global tyrosine protein kinase SYK market is further divided by geography, including North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).
Strengthening Research and Development Activity Across Europe
Europe continues to build momentum in kinase-targeted drug discovery, supported by strong academic–industry collaboration and regulatory frameworks encouraging innovative therapies. Cross-border research initiatives and biotechnology clusters are advancing small-molecule kinase inhibitor development, including multi-target approaches involving SYK signaling pathways. Ongoing licensing and partnership activity involving European stakeholders further supports regional participation in global SYK innovation. With sustained investment in immunology and rare disease research, Europe remains a strategically important region in the SYK therapeutics landscape.
North America Region Dominates the Market with Major Share
North America maintains a dominant position in the global SYK market due to robust clinical research infrastructure, strong biotechnology funding, and the presence of key developers advancing SYK inhibitors. Clinical-stage development programs, such as Rigel’s ongoing evaluation of fostamatinib in sickle cell disease, demonstrate continued pipeline activity in the region. In addition, significant licensing transactions involving U.S.-based biotech firms reflect active capital deployment toward kinase-based innovation. Regulatory support for targeted therapies and well-established commercialization channels further reinforce North America’s market leadership.
Market Players Outlook
The major companies operating in the global tyrosine protein kinase SYK market include Gilead Sciences, Inc., Hutchison China MediTech Limited, Kissei Pharmaceutical Co., Ltd., Rigel Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited, among others. Market players are leveraging partnerships, collaborations, mergers and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Developments
- In June 2025, Sanofi licensed gusacitinib, a dual JAK/SYK inhibitor from Formation Bio, in a transaction valued at up to €545 million to expand its immunology pipeline.
- In January 2025, Rigel Pharmaceuticals initiated a Phase I clinical trial of its oral SYK inhibitor fostamatinib in sickle cell disease, marking continued diversification of SYK-targeted indications.
The Report Covers
- Market value data analysis of 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global tyrosine protein kinase SYK Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Global Tyrosine Protein Kinase SYK Market Sales Analysis – Type | Application ($ Million)
- Tyrosine Protein Kinase SYK Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key Tyrosine Protein Kinase SYK Market Trends
- Market Recommendations
- Porter's Five Forces Analysis for the Tyrosine Protein Kinase SYK Market
- Competitive Rivalry
- Threat of New Entrants
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Market Determinants
- Market Drivers
- Drivers For Global Tyrosine Protein Kinase SYK Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For Global Tyrosine Protein Kinase SYK Market: Impact Analysis
- Market Opportunities
- Opportunities For Global Tyrosine Protein Kinase SYK Market: Impact Analysis
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – Tyrosine Protein Kinase SYK Market Revenue and Share by Manufacturers
- Tyrosine Protein Kinase SYK Product Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- Gilead Sciences, Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Hutchison China MediTech Limited
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Kissei Pharmaceutical Co., Ltd.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Rigel Pharmaceuticals, Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Takeda Pharmaceutical Company Limited
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership And Collaboration
- Gilead Sciences, Inc.
- Key Company Analysis
- Global Tyrosine Protein Kinase SYK Market Sales Analysis by Type ($ Million)
- HMPL-523
- C-13
- CVXL-0074
- ASN-002
- FF-10102
- Others
- Global Tyrosine Protein Kinase SYK Market Sales Analysis by Application ($ Million)
- Anaphylactic Shock
- Arthritis
- Fallopian Tube Cancer
- Lupus Nephritis
- Others
- Regional Analysis
- North American Tyrosine Protein Kinase SYK Market Sales Analysis – Type | Application | Country ($ Million)
- Macroeconomic Factors for North America
- United States
- Canada
- European Tyrosine Protein Kinase SYK Market Sales Analysis – Type | Application | Country ($ Million)
- Macroeconomic Factors for Europe
- UK
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia-Pacific Tyrosine Protein Kinase SYK Market Sales Analysis – Type | Application | Country ($ Million)
- Macroeconomic Factors for Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Other)
- Rest of Asia-Pacific
- Rest of the World Tyrosine Protein Kinase SYK Market Sales Analysis – Type | Application | Country ($ Million)
- Macroeconomic Factors for Rest of the World
- Latin America
- Middle East and Africa
- Company Profiles
- Asana BioSciences, LLC
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- AstraZeneca plc
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Bayer AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Bristol-Myers Squibb Company
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Celgene Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Daiichi Sankyo Company, Limited
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Hoffmann-La Roche Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Genosco Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Gilead Sciences, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- GlaxoSmithKline plc
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Hutchison China MediTech Limited
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Johnson & Johnson
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Kissei Pharmaceutical Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Merck & Co., Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Pfizer Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Rigel Pharmaceuticals, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Sanofi S.A.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Takeda Pharmaceutical Company Limited
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- UCB S.A.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Vertex Pharmaceuticals Incorporated
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Asana BioSciences, LLC
1. Global Tyrosine Protein Kinase SYK Market Research and Analysis by Type, 2025–2035 ($ Million)
2. Global HMPL-523 Tyrosine Protein Kinase SYK Market Research and Analysis by Region, 2025–2035 ($ Million)
3. Global C-13 Tyrosine Protein Kinase SYK Market Research and Analysis by Region, 2025–2035 ($ Million)
4. Global CVXL-0074 Tyrosine Protein Kinase SYK Market Research and Analysis by Region, 2025–2035 ($ Million)
5. Global ASN-002 Tyrosine Protein Kinase SYK Market Research and Analysis by Region, 2025–2035 ($ Million)
6. Global FF-10102 Tyrosine Protein Kinase SYK Market Research and Analysis by Region, 2025–2035 ($ Million)
7. Global Others Tyrosine Protein Kinase SYK Market Research and Analysis by Region, 2025–2035 ($ Million)
8. Global Tyrosine Protein Kinase SYK Market Research and Analysis by Application, 2025–2035 ($ Million)
9. Global Tyrosine Protein Kinase SYK For Anaphylactic Shock Market Research and Analysis by Region, 2025–2035 ($ Million)
10. Global Tyrosine Protein Kinase SYK For Arthritis Market Research and Analysis by Region, 2025–2035 ($ Million)
11. Global Tyrosine Protein Kinase SYK For Fallopian Tube Cancer Market Research and Analysis by Region, 2025–2035 ($ Million)
12. Global Tyrosine Protein Kinase SYK For Lupus Nephritis Market Research and Analysis by Region, 2025–2035 ($ Million)
13. Global Tyrosine Protein Kinase SYK For Others Market Research and Analysis by Region, 2025–2035 ($ Million)
14. Global Tyrosine Protein Kinase SYK Market Research and Analysis by Region, 2025–2035 ($ Million)
15. North American Tyrosine Protein Kinase SYK Market Research and Analysis by Country, 2025–2035 ($ Million)
16. North American Tyrosine Protein Kinase SYK Market Research and Analysis by Type, 2025–2035 ($ Million)
17. North American Tyrosine Protein Kinase SYK Market Research and Analysis by Application, 2025–2035 ($ Million)
18. European Tyrosine Protein Kinase SYK Market Research and Analysis by Country, 2025–2035 ($ Million)
19. European Tyrosine Protein Kinase SYK Market Research and Analysis by Type, 2025–2035 ($ Million)
20. European Tyrosine Protein Kinase SYK Market Research and Analysis by Application, 2025–2035 ($ Million)
21. Asia-Pacific Tyrosine Protein Kinase SYK Market Research and Analysis by Country, 2025–2035 ($ Million)
22. Asia-Pacific Tyrosine Protein Kinase SYK Market Research and Analysis by Type, 2025–2035 ($ Million)
23. Asia-Pacific Tyrosine Protein Kinase SYK Market Research and Analysis by Application, 2025–2035 ($ Million)
24. Rest of the World Tyrosine Protein Kinase SYK Market Research and Analysis by Region, 2025–2035 ($ Million)
25. Rest of the World Tyrosine Protein Kinase SYK Market Research and Analysis by Type, 2025–2035 ($ Million)
26. Rest of the World Tyrosine Protein Kinase SYK Market Research and Analysis by Application, 2025–2035 ($ Million)
1. Global Tyrosine Protein Kinase SYK Market Share by Type, 2025 Vs 2035 (%)
2. Global HMPL-523 Tyrosine Protein Kinase SYK Market Share by Region, 2025 Vs 2035 (%)
3. Global C-13 Tyrosine Protein Kinase SYK Market Share by Region, 2025 Vs 2035 (%)
4. Global CVXL-0074 Tyrosine Protein Kinase SYK Market Share by Region, 2025 Vs 2035 (%)
5. Global ASN-002 Tyrosine Protein Kinase SYK Market Share by Region, 2025 Vs 2035 (%)
6. Global FF-10102 Tyrosine Protein Kinase SYK Market Share by Region, 2025 Vs 2035 (%)
7. Global Others Tyrosine Protein Kinase SYK Market Share by Region, 2025 Vs 2035 (%)
8. Global Tyrosine Protein Kinase SYK Market Research and Analysis by Application, 2025 Vs 2035 (%)
9. Global Tyrosine Protein Kinase SYK For Anaphylactic Shock Market Share by Region, 2025 Vs 2035 (%)
10. Global Tyrosine Protein Kinase SYK For Arthritis Market Share by Region, 2025 Vs 2035 (%)
11. Global Tyrosine Protein Kinase SYK For Fallopian Tube Cancer Market Share by Region, 2025 Vs 2035 (%)
12. Global Tyrosine Protein Kinase SYK For Lupus Nephritis Market Share by Region, 2025 Vs 2035 (%)
13. Global Tyrosine Protein Kinase SYK For Others Market Share by Region, 2025 Vs 2035 (%)
14. Global Tyrosine Protein Kinase SYK Market Research and Analysis by Region, 2025–2035 ($ Million)
15. US Tyrosine Protein Kinase SYK Market Size, 2025–2035 ($ Million)
16. Canada Tyrosine Protein Kinase SYK Market Size, 2025–2035 ($ Million)
17. UK Tyrosine Protein Kinase SYK Market Size, 2025–2035 ($ Million)
18. France Tyrosine Protein Kinase SYK Market Size, 2025–2035 ($ Million)
19. Germany Tyrosine Protein Kinase SYK Market Size, 2025–2035 ($ Million)
20. Italy Tyrosine Protein Kinase SYK Market Size, 2025–2035 ($ Million)
21. Spain Tyrosine Protein Kinase SYK Market Size, 2025–2035 ($ Million)
22. Russia Tyrosine Protein Kinase SYK Market Size, 2025–2035 ($ Million)
23. Rest of Europe Tyrosine Protein Kinase SYK Market Size, 2025–2035 ($ Million)
24. India Tyrosine Protein Kinase SYK Market Size, 2025–2035 ($ Million)
25. China Tyrosine Protein Kinase SYK Market Size, 2025–2035 ($ Million)
26. Japan Tyrosine Protein Kinase SYK Market Size, 2025–2035 ($ Million)
27. South Korea Tyrosine Protein Kinase SYK Market Size, 2025–2035 ($ Million)
28. Australia and New Zealand Tyrosine Protein Kinase SYK Market Size, 2025–2035 ($ Million)
29. ASEAN Economies Tyrosine Protein Kinase SYK Market Size, 2025–2035 ($ Million)
30. Rest of Asia-Pacific Tyrosine Protein Kinase SYK Market Size, 2025–2035 ($ Million)
31. Latin America Tyrosine Protein Kinase SYK Market Size, 2025–2035 ($ Million)
32. Middle East and Africa Tyrosine Protein Kinase SYK Market Size, 2025–2035 ($ Million)
- Printable version
- No restriction to number of user within the company
Contact Sales
FAQS
The size of the Tyrosine Protein Kinase SYK Market in 2025 is estimated to be around $355.2 million.
North America holds the largest share in the Tyrosine Protein Kinase SYK Market.
Leading players in the Tyrosine Protein Kinase SYK Market include Gilead Sciences, Inc., Hutchison China MediTech Limited, Kissei Pharmaceutical Co., Ltd., Rigel Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited, among others.
The Tyrosine Protein Kinase SYK Market is expected to grow at a CAGR of 8.8% from 2026 to 2035.
The Tyrosine Protein Kinase SYK Market growth is driven by increasing research in autoimmune and hematologic disorders and rising development of targeted kinase inhibitor therapies.
